Literature DB >> 11715083

Stereological cell counts of GABAergic neurons in rat dentate hilus following transient cerebral ischemia.

G J Müller1, A Møller, F F Johansen.   

Abstract

We have previously demonstrated a 60-80% ischemic loss of somatostatinergic neurons in the dorsal dentate hilus of the rat. However, several studies have failed to demonstrate ischemic loss of GABAergic neurons in hilus, although one study reports that 96% of the somatostatinergic neurons in the dorsal hilus colocalize GABA. In order to understand this paradox, we have now estimated, using unbiased stereology, the total number of neurons immunohistochemically stained against glutamic acid decarboxylase-65 (GAD65) and GAD67 in the dorsal dentate hilus. Rats were divided into groups subjected to either sham operation (n=8) or 8 min of transient global ischemia during systemic hypotension (n=8) and allowed to survive for 7-9 days. Results from cell counts (mean +/- SD) in sham rats demonstrated that the dorsal hilus contains 9,189+/-3,957 GAD65 neurons and 6,991+/-2,784 GAD67 neurons. After ischemia, corresponding cell counts demonstrated 10,216+/-4,866 GAD65 neurons and 10,119+/-5,906 GAD67 neurons, and these results were not significantly different (P>0.05) from results in sham rats. Power analysis of the t-test informs that losses less than 80% are not significant and reflects the excessive variance in our material. For comparison, we estimated a total of 21% ischemic neuron death in the dorsal hilus on cresyl violet-stained sections from other corresponding sham (n=7) and ischemic rats (n=7). This explains why ischemic loss of hilar GABAergic neurons can only be detected by counts of the vulnerable subpopulation colocalizing somatostatin. Our investigation has demonstrated a surprisingly high variation between rats in a number of GAD-immunopositive neurons located in the dorsal dentate hilus, which is related to variations between the individual rats and neurons in their endogenous GAD expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11715083     DOI: 10.1007/s002210100879

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  6 in total

1.  Repetitive closed-skull traumatic brain injury in mice causes persistent multifocal axonal injury and microglial reactivity.

Authors:  Yoshitsugu Shitaka; Hien T Tran; Rachel E Bennett; Laura Sanchez; Marilyn A Levy; Krikor Dikranian; David L Brody
Journal:  J Neuropathol Exp Neurol       Date:  2011-07       Impact factor: 3.685

2.  Expression of glutamic acid decarboxylase and identification of GABAergic cells in the ischemic rat dentate gyrus.

Authors:  Georg Johannes Müller; Anne-Marie Dogonowski; Bente Finsen; Flemming Fryd Johansen
Journal:  Exp Brain Res       Date:  2006-08-12       Impact factor: 1.972

3.  Stereological estimates of the basal forebrain cell population in the rat, including neurons containing choline acetyltransferase, glutamic acid decarboxylase or phosphate-activated glutaminase and colocalizing vesicular glutamate transporters.

Authors:  I Gritti; P Henny; F Galloni; L Mainville; M Mariotti; B E Jones
Journal:  Neuroscience       Date:  2006-11-03       Impact factor: 3.590

4.  Immunohistochemical markers for quantitative studies of neurons and glia in human neocortex.

Authors:  Lise Lyck; Ishar Dalmau; John Chemnitz; Bente Finsen; Henrik Daa Schrøder
Journal:  J Histochem Cytochem       Date:  2007-11-12       Impact factor: 2.479

5.  A sequential impairment of cortical astrocytes and GABAergic neurons during ischemia is improved by mGluR₁,₅ activation.

Authors:  Zhan Liu; Wei Huo; Wei Sun; Manhua Lv; Fang Li; Zhiqiang Su
Journal:  Neurol Sci       Date:  2012-10-31       Impact factor: 3.307

6.  MDMA increases glutamate release and reduces parvalbumin-positive GABAergic cells in the dorsal hippocampus of the rat: role of cyclooxygenase.

Authors:  John H Anneken; Jacobi I Cunningham; Stuart A Collins; Bryan K Yamamoto; Gary A Gudelsky
Journal:  J Neuroimmune Pharmacol       Date:  2012-11-18       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.